The Value of PAREXEL Strategic Partnerships in Japan - Josh Schultz

October 29, 2013
Josh Schultz, VP Clinical Research Services explains the value of building and implementing strategic partnerships in Japan including reduced cost, speed and ability to reduce oversight made possible by robust trust but verify schemes, implementations of details acceptance criteria, comprehensive governance and data technologies.
Previous Video
How Outsourcing is Expected to Evolve in Japan - Josef von Rickenbach
How Outsourcing is Expected to Evolve in Japan - Josef von Rickenbach

Josef von Rickenbach, Chairman and CEO of PAREXEL explains opportunities around the evolution of outsourcin...

Next Video
Drug Development Trends in Asia/Pacific - Albert Liou
Drug Development Trends in Asia/Pacific - Albert Liou

Albert Liou Corporate Vice President and General Manager at PAREXEL, comments on the drug development trend...